- Home
- TRVI vs CRMT Comparison
TRVI vs CRMT Comparison
Compare TRVI & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- CRMT
- Stock Information
- Founded
- TRVI 2011
- CRMT 1981
- Country
- TRVI United States
- CRMT United States
- Employees
- TRVI N/A
- CRMT N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- CRMT Other Specialty Stores
- Sector
- TRVI Health Care
- CRMT Consumer Discretionary
- Exchange
- TRVI Nasdaq
- CRMT Nasdaq
- Market Cap
- TRVI 383.4M
- CRMT 375.4M
- IPO Year
- TRVI 2019
- CRMT N/A
- Fundamental
- Price
- TRVI $6.07
- CRMT $48.05
- Analyst Decision
- TRVI Strong Buy
- CRMT Hold
- Analyst Count
- TRVI 8
- CRMT 2
- Target Price
- TRVI $17.56
- CRMT $50.00
- AVG Volume (30 Days)
- TRVI 1.6M
- CRMT 88.8K
- Earning Date
- TRVI 05-06-2025
- CRMT 06-17-2025
- Dividend Yield
- TRVI N/A
- CRMT N/A
- EPS Growth
- TRVI N/A
- CRMT N/A
- EPS
- TRVI N/A
- CRMT 1.04
- Revenue
- TRVI N/A
- CRMT $1,380,231,000.00
- Revenue This Year
- TRVI N/A
- CRMT $1.73
- Revenue Next Year
- TRVI N/A
- CRMT $5.52
- P/E Ratio
- TRVI N/A
- CRMT $46.10
- Revenue Growth
- TRVI N/A
- CRMT N/A
- 52 Week Low
- TRVI $2.30
- CRMT $36.40
- 52 Week High
- TRVI $7.39
- CRMT $72.26
- Technical
- Relative Strength Index (RSI)
- TRVI 54.54
- CRMT 56.83
- Support Level
- TRVI $4.85
- CRMT $42.45
- Resistance Level
- TRVI $6.15
- CRMT $47.39
- Average True Range (ATR)
- TRVI 0.50
- CRMT 3.09
- MACD
- TRVI -0.04
- CRMT 0.22
- Stochastic Oscillator
- TRVI 73.94
- CRMT 89.98
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About CRMT America's Car-Mart Inc
America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and in the majority of the cases a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.